Bolt Biotherapeutics, Inc. (BOLT)

CIK 1641281 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bolt Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G0001037389-26-000047
Aug 11, 202610-Q0001193125-26-344597
Aug 11, 20268-K0001193125-26-344580
Jun 11, 202640001193125-26-267518
Jun 11, 202640001193125-26-267533
Jun 11, 202640001193125-26-267546
Jun 11, 202640001193125-26-267558
Jun 11, 202640001193125-26-267560
Jun 11, 20268-K0001193125-26-267487
May 12, 20268-K0001193125-26-219361
May 12, 202610-Q0001193125-26-219382
Apr 28, 2026DEFA14A0001193125-26-186940
Apr 28, 2026ARS0001193125-26-186950
Apr 28, 2026DEF 14A0001193125-26-186923
Mar 12, 2026S-80001193125-26-104164
Mar 12, 202610-K0001193125-26-104121
Mar 12, 20268-K0001193125-26-104102
Feb 26, 2026SCHEDULE 13D/A0001012975-26-000212
Feb 17, 2026SCHEDULE 13D/A0001012975-26-000173
Feb 13, 2026SCHEDULE 13G/A0001213900-26-016669
Feb 4, 202640001193125-26-037692
Feb 4, 202640001193125-26-037697
Feb 4, 202640001193125-26-037690
Dec 16, 202540001193125-25-321154
Dec 16, 202540001193125-25-321152